BAKER BROS. ADVISORS LP 13D and 13G filings for Replimune Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-03-07 5:07 pm Unchanged |
2025-03-07 | 13D | Replimune Group, Inc. REPL |
BAKER BROS. ADVISORS LP | 11,045,336 14.300% |
0 (Unchanged) |
Filing |
2024-11-14 4:20 pm Purchase |
2024-09-30 | 13G | Replimune Group, Inc. REPL |
BAKER BROS. ADVISORS LP | 11,045,336 16.200% |
1,500,000![]() (+15.71%) |
Filing |
2024-01-10 4:57 pm Purchase |
2023-12-31 | 13G | Replimune Group, Inc. REPL |
BAKER BROS. ADVISORS LP | 9,545,336 16.200% |
3,777,109![]() (+65.48%) |
Filing |
2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
BAKER BROS. ADVISORS LP | 5,768,227 9.990% |
5,768,227![]() (New Position) |
Filing |